DrugPatentWatch Database Preview

Drugs in Development Information for Glembatumumab vedotin

« Back to Dashboard

Summary for Glembatumumab vedotin

US Patents	5
International Patents	45
US Patent Applications	0
WIPO Patent Applications	0
Japanese Patent Applications	0
Clinical Trial Progress	Phase 2 (2013-11-01)
Vendors	0

US Patents for Glembatumumab vedotin

Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
Glembatumumab vedotin		Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein	CureVac AG (Tubingen, DE)
Glembatumumab vedotin		P97 fragments with transfer activity	biOasis Technologies, Inc. (Vancouver, British Columbia, unknown)
Glembatumumab vedotin		Fragments of p97 and uses thereof	biOasis Technologies, Inc. (Richmond, CA)
Glembatumumab vedotin		Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein	CureVac AG (Tubingen, DE)

International Patents for Glembatumumab vedotin

Drugname	Country	Document Number	Estimated Expiration	Related US Patent
Glembatumumab vedotin	Australia	2013220749	2032-02-15
Glembatumumab vedotin	Brazil	112014019627	2032-02-15
Glembatumumab vedotin	Canada	2862476	2032-02-15
Glembatumumab vedotin	China	104114705	2032-02-15